255
Participants
Start Date
July 25, 2014
Primary Completion Date
August 31, 2019
Study Completion Date
August 19, 2019
Methotrexate
Two Dose Protocol: The patient will receive the first dose of MTX 50mg/m2 on treatment day 0. She will receive a second dose of MTX 50mg/m2 on treatment day 4 and a serum hCG level will be drawn. Subsequent doses of MTX will be administered based on hCG levels.
Uterine Evacuation
Uterine evacuation or dilation and curettage. At the clinician's discretion, this can be performed using local anesthesia, sedation or general anesthesia and can use a manual or electrical evacuation.
Expectant Management
Pregnancy will be expectantly managed using serum hcg monitoring
University of Rochester, Rochester
University of Pennsylvania, Philadelphia
University of North Carolina, Chapel Hill
Duke University, Durham
Carolinas Medical Center - Women's Institute, Charlotte
Greenville Health System, Greenville
Augusta University, Augusta
University of South Florida, Tampa
Wayne State University, Southfield
Northwestern University, Chicago
University Of Illinois at Chicago, Chicago
Washington University, St Louis
University of Oklahoma, Oklahoma City
Denver Health, Denver
University of Utah, Salt Lake City
University of California San Francisco, San Francisco
Yale University, New Haven
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Augusta University
OTHER
Penn State University
OTHER
University of California, San Francisco
OTHER
University of North Carolina
OTHER
University of Oklahoma
OTHER
University of Pennsylvania
OTHER
Yale University
OTHER